Following bankruptcy, 23andMe’s vast genetic database is seen as a lucrative asset for AI companies. However, privacy concerns over data sales could pose significant ethical and security challenges. The implications affect users globally, with advancements in data utilization techniques by potential buyers pending regulation.
Read More:
- đź”— time.com